Evidence map›Paper›PMID 38261145›Full record

ReviewCurrent neurology and neuroscience reports2024

Lobar Microbleeds in the Posterior Cortical Atrophy Syndrome: A Comparison to Typical Alzheimer's Disease.

Victoria S Pelak, Vishal Krishnan, Stephanie Serva, Peter Pressman, Asher Mahmood, Lily Noteboom, Brianne M Bettcher, Stefan H Sillau, Andrew L Callen, Ashesh A Thaker

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current neurology and neuroscience reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Victoria S PelakDepartment of Neurology, University of Colorado School of Medicine, 12631 East 17 Avenue, Mail Stop B185, Aurora, CO, 80045, USA. Victoria.Pelak@CUAnschutz.edu.ORCID 0000-0003-3147-8595
Vishal KrishnanDepartment of Neurology, University of Colorado School of Medicine, 12631 East 17 Avenue, Mail Stop B185, Aurora, CO, 80045, USA.
Stephanie ServaDepartment of Neurology, University of Colorado School of Medicine, 12631 East 17 Avenue, Mail Stop B185, Aurora, CO, 80045, USA.
Peter PressmanDepartment of Neurology, University of Colorado School of Medicine, 12631 East 17 Avenue, Mail Stop B185, Aurora, CO, 80045, USA.
Asher MahmoodDepartment of Neurology, University of Colorado School of Medicine, 12631 East 17 Avenue, Mail Stop B185, Aurora, CO, 80045, USA.
Lily NoteboomDepartment of Neurology, University of Colorado School of Medicine, 12631 East 17 Avenue, Mail Stop B185, Aurora, CO, 80045, USA.
Brianne M BettcherDepartment of Neurology, University of Colorado School of Medicine, 12631 East 17 Avenue, Mail Stop B185, Aurora, CO, 80045, USA.
Stefan H SillauDepartment of Neurology, University of Colorado School of Medicine, 12631 East 17 Avenue, Mail Stop B185, Aurora, CO, 80045, USA.
Andrew L CallenDepartment of Radiology, University of Colorado School of Medicine, Aurora, CO, USA.
Ashesh A ThakerDepartment of Radiology, University of Colorado School of Medicine, Aurora, CO, USA.
University of Colorado Denver · US

Funding

Phase II trial of GM-CSF/sargramostim in Alzheimer's DiseaseR01AG071151 · NIA · UNIVERSITY OF COLORADO DENVER · PI Huntington Potter · 2021 to 2026
$7.5M
Investigating the Contribution of Peripheral versus Central Nervous System Immune Dysfunction to Cognitive AgingR01AG058772 · NIA · UNIVERSITY OF COLORADO DENVER · PI BETTCHER, BRIANNE MAGOUIRK · 2019 to 2023
$3.7M
GM-CSF/sargramostim treatment to improve cognition in Down syndromeR61AG074859 · NIA · UNIVERSITY OF COLORADO DENVER · PI POTTER, HUNTINGTON · 2021 to 2022
$1.2M
Computational Speech Analysis in Alzheimer's Disease and Other Neurocognitive Disorders (Supplement)K23AG063900 · NIA · UNIVERSITY OF COLORADO DENVER · PI PRESSMAN, PETER SCOTT · 2020 to 2024
$980k
Integrating Home-Based Video Teleneuropsychology into Clinical Practice: Typical Versus Atypical Alzheimer's DiseaseR21AG072153 · NIA · UNIVERSITY OF COLORADO DENVER · PI BETTCHER, BRIANNE MAGOUIRK · 2022 to 2023
$428k
NIA NIH HHS K23 AG063900NIA NIH HHS R01 AG058772NIA NIH HHS R01 AG071151NIA NIH HHS R21 AG072153NIA NIH HHS R61 AG074859
6 · The paper itself

Abstract

purpose of the studyPosterior cortical atrophy is a clinico-radiographical syndrome that presents with higher-order visual dysfunction and is most commonly due to Alzheimer's disease. Understanding factors associated with atypical presentations of Alzheimer's disease, such as posterior cortical atrophy (PCA), holds promise to shape our understanding of AD pathophysiology. Thus, we aimed to compare MRI evidence of lobar microbleeds (LMBs) in posterior cortical atrophy (PCA) syndrome to typical AD (tAD) and to assess and compare MRI evidence of cerebral amyloid angiopathy (CAA) in each group.

findingsWe retrospectively collected clinical and MRI data from participants with PCA (n = 26), identified from an institutional PCA registry, and participants with tAD (n = 46) identified from electronic health records from a single institution. LMBs were identified on susceptibility-weighted imaging (SWI); the Fazekas grade of white matter disease was assessed using FLAIR images, and Boston criteria version 2.0 for cerebral amyloid angiopathy were applied to all data. The proportion of participants with PCA and LMB (7.7%) was lower than for tAD (47.8%) (p = 0.005). The frequency of "probable" CAA was similar in both groups, while "possible" CAA was more frequent in tAD (30.4%) than PCA (0%) (p = 0.001). The Fazekas grades were not different between groups. Lobar microbleeds on SWI were not more common in PCA than in typical AD. Clinicopathological investigations are necessary to confirm these findings. The factors that contribute to the posterior cortical atrophy phenotype are unknown.

Indexed as

Alzheimer DiseaseCerebral Amyloid AngiopathyAtrophyCerebral HemorrhageHumansMagnetic Resonance ImagingRetrospective StudiesAlzheimer’s diseaseAtypical Alzheimer’s diseaseCerebral amyloid angiopathyLobar microbleedsPosterior cortical atrophy

Identifiers

PMID38261145
OpenAlexW4391126375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.